Response to Pyrotinib in a Patient with Metastatic Bladder Urothelial Carcinoma Harboring HER2 V842I Mutation: A Case Report

Suyao Li,1,* Qing Liu,1,2,* Mengling Liu,1 Tianshu Liu1,2 1Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China; 2Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China*These authors contributed equa...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Li S, Liu Q, Liu M, Liu T
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Dove Medical Press 2022-09-01
Schriftenreihe:	Cancer Management and Research
Schlagworte:	bladder cancer pyrotinib v842i mutation human epidermal growth factor receptor 2 next-generation sequencing
Online-Zugang:	https://www.dovepress.com/response-to-pyrotinib-in-a-patient-with-metastatic-bladder-urothelial--peer-reviewed-fulltext-article-CMAR
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!